Related Experiment Video
Updated: Aug 1, 2026
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Modeling Parkinson's disease in midbrain-like organoids
Lisa M Smits1, Lydia Reinhardt2,3, Peter Reinhardt2,3,4
11Luxembourg Centre for Systems Biomedicine (LCSB), Developmental and Cellular Biology, University of Luxembourg, Belvaux, Luxembourg.
NPJ Parkinson'S Disease
|April 10, 2019
Summary
This study introduces 3D human midbrain organoids for Parkinson's disease (PD) research. These organoids model key PD features, including dopaminergic neuron defects, offering a new tool for studying neurodegenerative disorders.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of midbrain dopaminergic neurons.
- Advanced in vitro models are crucial for understanding PD mechanisms and exploring therapeutic strategies.
- Current models often lack the complexity to fully recapitulate human midbrain development and disease pathology.
Purpose of the Study:
- To develop and validate a 3D human midbrain organoid model for studying Parkinson's disease.
- To investigate the impact of the LRRK2-G2019S mutation on midbrain dopaminergic neuron development and function.
- To establish a robust platform for mechanistic studies and drug screening in Parkinson's disease.
Main Methods:
- Three-dimensional (3D) differentiation of expandable midbrain floor plate neural progenitor cells (mfNPCs).
- Generation of midbrain organoids containing midbrain dopaminergic neurons (mDANs) that produce dopamine.
- Utilizing automated high-content image analysis to quantify mDANs and assess neurodevelopmental markers (e.g., FOXA2).
- Comparison of organoids derived from healthy controls and PD patients with the LRRK2-G2019S mutation.
Main Results:
- Successfully generated 3D human midbrain organoids resembling key features of the human midbrain, including mDANs.
- PD patient-derived organoids carrying the LRRK2-G2019S mutation exhibited disease-relevant phenotypes.
- A significant decrease in the number and complexity of mDANs was observed in LRRK2-G2019S organoids compared to controls.
- Increased expression of the floor plate marker FOXA2 in PD organoids suggests a potential neurodevelopmental defect.
Conclusions:
- The developed 3D human midbrain organoid model provides a powerful tool for studying Parkinson's disease.
- This model effectively recapitulates LRRK2-G2019S-associated PD phenotypes, aiding in the investigation of disease mechanisms.
- The findings highlight potential neurodevelopmental defects in mDANs linked to the LRRK2-G2019S mutation, offering new avenues for PD research.
